HOOKIPA reports Gilead support for potential Poolbeg acquisition; fundraise revised to $30M+ primary placement

HOOKIPA Pharma Inc.

Gilead, owning 19.4% of HOOKIPA shares, signals intent to vote for the deal and join the $30M+ fundraise.
HOOKIPA revised fundraise to ~$30M+ primary private placement (previously up to ~$30M).
Oppenheimer & Co. Inc. engaged as placement agent for the private placement fundraise.
Discussions remain non-binding; no assurance a firm offer will be made or deal completed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.